Clinical Trial Update: Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

Clinical trial update for Amlodipine/Atorvastatin (Caduet) under regulatory post-marketing commitments; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hypertension

Drugs mentioned

• Caduet (amlodipine/atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Hypertension, Angina Pectoris | Status: COMPLETED | Results posted: 2013-05-30